COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection

JAMA. 2020 Aug 18;324(7):623-624. doi: 10.1001/jama.2020.13170.
No abstract available

MeSH terms

  • Animals
  • COVID-19 / complications
  • COVID-19 / drug therapy*
  • Dexamethasone / adverse effects*
  • Dexamethasone / therapeutic use
  • Humans
  • Immunocompromised Host
  • Strongyloides stercoralis
  • Strongyloidiasis / etiology
  • Strongyloidiasis / prevention & control*

Substances

  • Dexamethasone

Supplementary concepts

  • COVID-19 drug treatment